SGO: Drug Combination Slows Recurrent Ovarian Cancer (CME/CE)

posted on Mar 15 by MedPage Today OB/Gyn in the Uncategorized category SAN FRANCISCO (MedPage Today) -- Combination chemotherapy resulted in a longer, progression-free survival (PFS) than did sequential therapy in a randomized clinical trial of patients with recurrent, platinum-sensitive ovarian cancer.